SCYNEXIS, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.
Checking data access...
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.
Start for Free